Highlights
KLSE: AHEALTH (7090)       APEX HEALTHCARE BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
3.37   +0.12 (3.69%)  3.24 - 3.39  313,300
Analyze this stock with MQ Trader system

Financials


Market Cap: 1,601 Million

Market Cap 1,601 Million
NOSH 475 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 05-Jun-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 05-Jun-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Jun-2020 [#2]

Latest Quarter: 30-Jun-2020 [#2]
Announcement Date 26-Aug-2020
Next Quarter: 30-Sep-2020
Est. Ann. Date: 21-Nov-2020
Est. Ann. Due Date: 29-Nov-2020
QoQ | YoY   -9.30%  |    -1.44%

Annual (Unaudited) ( EPS: 11.11, P/E: 30.35 )

Revenue | NP to SH 688,786  |  52,750
RPS | P/RPS 145.00 Cent  |  2.32
EPS | P/E | EY 11.11 Cent  |  30.35  |  3.30%
DPS | DY | Payout % 3.67 Cent  |  1.09%  |  33.06%
NAPS | P/NAPS 0.89  |  3.77
YoY   -9.95%
NP Margin | ROE 7.66%  |  12.44%
F.Y. | Ann. Date 31-Dec-2019  |  19-Feb-2020

T4Q Result ( EPS: 11.69, P/E: 28.83 )

Revenue | NP to SH 719,323  |  55,531
RPS | P/RPS 151.43 Cent  |  2.23
EPS | P/E | EY 11.69 Cent  |  28.83  |  3.47%
DPS | DY | Payout % 3.68 Cent  |  1.09%  |  31.44%
NAPS | P/NAPS 0.94  |  3.60
QoQ | YoY   -0.34%  |    -1.41%
NP Margin | ROE 7.70%  |  12.50%
F.Y. | Ann. Date 30-Jun-2020  |  26-Aug-2020

Annualized Result ( EPS: 11.54, P/E: 29.21 )

Revenue | NP to SH 736,072  |  54,808
RPS | P/RPS 154.96 Cent  |  2.17
EPS | P/E | EY 11.54 Cent  |  29.21  |  3.42%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -4.65%  |    11.29%
NP Margin | ROE 7.42%  |  12.34%
F.Y. | Ann. Date 30-Jun-2020  |  26-Aug-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2020 26-Aug-2020 30-Jun-2020 2 174,728 16,341 12,930 13,034 8,032 444,145 61.63% 7.40% 2.93% 472,495 36.98 36.78 2.76 2.74 1.70 1.69 0.9400 0.94   -9.30%   -1.44% 30-Jun-2020 2.80 7.57 101.50 2.98 0.99% 0.61% 26-Aug-2020 3.72 10.06 134.85 3.96 0.74% 0.46%
31-Dec-2020 21-May-2020 31-Mar-2020 1 193,308 17,944 14,362 14,370 - 438,661 - % 7.43% 3.28% 471,679 40.98 40.70 3.05 3.03 0.00 0.00 0.9300 0.92   2.61%   26.06% 31-Mar-2020 2.11 5.15 69.26 2.27 1.44% 0.00% 21-May-2020 2.90 7.08 95.19 3.12 1.05% 0.00%
31-Dec-2019 19-Feb-2020 31-Dec-2019 4 170,634 18,484 14,006 14,004 9,426 424,170 67.31% 8.21% 3.30% 471,301 36.20 35.92 2.97 2.95 2.00 1.98 0.9000 0.89   -0.84%   -16.66% 31-Dec-2019 2.24 6.19 75.39 2.49 1.33% 0.89% 19-Feb-2020 2.41 6.66 81.11 2.68 1.23% 0.83%
31-Dec-2019 21-Nov-2019 30-Sep-2019 3 180,653 17,124 14,122 14,123 - 409,992 - % 7.82% 3.44% 471,256 38.33 38.03 3.00 2.97 0.00 0.00 0.8700 0.86   6.80%   -5.20% 30-Sep-2019 2.18 5.69 72.74 2.51 1.37% 0.00% 21-Nov-2019 2.40 6.26 80.08 2.76 1.25% 0.00%
31-Dec-2019 21-Aug-2019 30-Jun-2019 2 159,270 16,183 13,230 13,224 8,008 405,125 60.56% 8.31% 3.26% 471,076 33.81 33.53 2.81 2.78 1.70 1.69 0.8600 0.85   16.01%   -3.47% 28-Jun-2019 2.17 6.42 77.30 2.52 1.29% 0.78% 21-Aug-2019 2.03 6.00 72.31 2.36 1.38% 0.84%
31-Dec-2019 23-May-2019 31-Mar-2019 1 178,229 14,543 11,414 11,399 - 392,099 - % 6.40% 2.91% 117,395 151.82 37.52 9.71 2.40 0.00 0.00 3.3400 0.83   -32.16%   -13.52% 29-Mar-2019 8.87 5.84 91.35 2.66 1.09% 0.00% 23-May-2019 8.60 5.66 88.57 2.57 1.13% 0.00%
31-Dec-2018 28-Feb-2019 31-Dec-2018 4 163,061 16,739 16,803 16,804 8,210 381,202 48.86% 10.30% 4.41% 117,293 139.02 34.33 14.33 3.54 7.00 1.73 3.2500 0.80   12.80%   31.27% 31-Dec-2018 7.80 5.61 54.44 2.40 1.84% 0.90% 28-Feb-2019 8.95 6.44 62.47 2.75 1.60% 0.78%
31-Dec-2018 15-Nov-2018 30-Sep-2018 3 165,253 18,637 14,942 14,897 - 365,595 - % 9.04% 4.07% 117,178 141.03 34.79 12.71 3.14 0.00 0.00 3.1200 0.77   8.75%   32.18% 28-Sep-2018 8.25 5.85 64.89 2.64 1.54% 0.00% 15-Nov-2018 8.10 5.74 63.71 2.60 1.57% 0.00%
31-Dec-2018 16-Aug-2018 30-Jun-2018 2 155,946 17,368 13,701 13,699 7,614 360,809 55.58% 8.79% 3.80% 117,146 133.12 32.83 11.69 2.88 6.50 1.60 3.0800 0.76   3.93%   33.04% 29-Jun-2018 6.79 5.10 58.06 2.20 1.72% 0.96% 16-Aug-2018 7.25 5.45 62.00 2.35 1.61% 0.90%
31-Dec-2018 24-May-2018 31-Mar-2018 1 168,400 16,526 13,221 13,181 - 356,123 - % 7.85% 3.70% 117,146 143.75 35.45 11.25 2.77 0.00 0.00 3.0400 0.75   2.97%   30.62% 30-Mar-2018 5.48 3.81 48.70 1.80 2.05% 0.00% 24-May-2018 5.76 4.01 51.19 1.89 1.95% 0.00%
31-Dec-2017 22-Feb-2018 31-Dec-2017 4 152,585 16,380 12,799 12,801 7,614 343,237 59.48% 8.39% 3.73% 117,146 130.25 32.12 10.93 2.69 6.50 1.60 2.9300 0.72   13.58%   89.48% 29-Dec-2017 5.60 4.30 51.25 1.91 1.95% 1.16% 22-Feb-2018 4.90 3.76 44.84 1.67 2.23% 1.33%
31-Dec-2017 14-Nov-2017 30-Sep-2017 3 157,730 13,302 11,290 11,270 - 330,351 - % 7.16% 3.41% 117,146 134.64 33.21 9.62 2.37 0.00 0.00 2.8200 0.70   9.45%   29.01% 29-Sep-2017 5.10 3.79 53.01 1.81 1.89% 0.00% 14-Nov-2017 5.50 4.08 57.17 1.95 1.75% 0.00%
31-Dec-2017 16-Aug-2017 30-Jun-2017 2 155,297 13,453 10,300 10,297 6,443 325,665 62.57% 6.63% 3.16% 117,146 132.57 32.69 8.79 2.17 5.50 1.36 2.7800 0.69   2.04%   6.72% 30-Jun-2017 4.70 3.55 53.47 1.69 1.87% 1.17% 16-Aug-2017 4.74 3.58 53.93 1.71 1.85% 1.16%
31-Dec-2017 17-May-2017 31-Mar-2017 1 154,652 12,912 10,099 10,091 - 322,151 - % 6.53% 3.13% 117,146 132.02 32.56 8.61 2.12 0.00 0.00 2.7500 0.68   49.36%   2.83% 31-Mar-2017 4.90 3.71 56.88 1.78 1.76% 0.00% 17-May-2017 4.70 3.56 54.56 1.71 1.83% 0.00%
31-Dec-2016 23-Feb-2017 31-Dec-2016 4 144,146 10,079 6,766 6,756 7,028 311,608 104.04% 4.69% 2.17% 117,146 123.05 30.35 5.77 1.42 6.00 1.48 2.6600 0.66   -22.66%   -51.06% 30-Dec-2016 4.30 3.49 74.56 1.62 1.34% 1.40% 23-Feb-2017 4.65 3.78 80.63 1.75 1.24% 1.29%
31-Dec-2016 15-Nov-2016 30-Sep-2016 3 142,960 11,536 8,748 8,736 - 301,065 - % 6.12% 2.90% 117,146 122.04 30.10 7.46 1.84 0.00 0.00 2.5700 0.63   -9.46%   62.35% 30-Sep-2016 4.54 3.72 60.88 1.77 1.64% 0.00% 15-Nov-2016 4.60 3.77 61.68 1.79 1.62% 0.00%
31-Dec-2016 17-Aug-2016 30-Jun-2016 2 146,685 12,313 9,655 9,649 6,443 298,722 66.77% 6.58% 3.23% 117,146 125.22 30.88 8.24 2.03 5.50 1.36 2.5500 0.63   -1.67%   46.13% 30-Jun-2016 3.89 3.11 47.23 1.53 2.12% 1.41% 17-Aug-2016 3.82 3.05 46.38 1.50 2.16% 1.44%
31-Dec-2016 18-May-2016 31-Mar-2016 1 147,478 12,366 9,819 9,813 - 296,379 - % 6.66% 3.31% 117,146 125.89 31.05 8.38 2.07 0.00 0.00 2.5300 0.62   -28.92%   16.19% 31-Mar-2016 3.73 2.96 44.53 1.47 2.25% 0.00% 18-May-2016 3.94 3.13 47.04 1.56 2.13% 0.00%
31-Dec-2015 25-Feb-2016 31-Dec-2015 4 134,248 17,165 13,827 13,806 7,028 288,179 50.91% 10.30% 4.79% 117,146 114.60 28.26 11.79 2.91 6.00 1.48 2.4600 0.61   156.57%   44.64% 31-Dec-2015 3.60 3.14 30.55 1.46 3.27% 1.67% 25-Feb-2016 3.41 2.98 28.93 1.39 3.46% 1.76%
31-Dec-2015 26-Nov-2015 30-Sep-2015 3 128,268 7,721 5,388 5,381 - 274,121 - % 4.20% 1.96% 117,146 109.49 27.00 4.59 1.13 0.00 0.00 2.3400 0.58   -18.51%   -27.38% 30-Sep-2015 3.95 3.61 85.99 1.69 1.16% 0.00% 26-Nov-2015 3.70 3.38 80.55 1.58 1.24% 0.00%
31-Dec-2015 19-Aug-2015 30-Jun-2015 2 124,279 9,076 6,602 6,603 5,857 268,264 88.71% 5.31% 2.46% 117,146 106.09 26.16 5.64 1.39 5.00 1.23 2.2900 0.56   -21.82%   -12.59% 30-Jun-2015 4.02 3.79 71.32 1.76 1.40% 1.24% 19-Aug-2015 3.95 3.72 70.08 1.72 1.43% 1.27%
31-Dec-2015 20-May-2015 31-Mar-2015 1 140,064 11,880 8,446 8,446 - 268,264 - % 6.03% 3.15% 117,146 119.56 29.49 7.21 1.78 0.00 0.00 2.2900 0.56   -11.51%   -10.79% 31-Mar-2015 3.90 3.26 54.09 1.70 1.85% 0.00% 20-May-2015 3.95 3.30 54.79 1.72 1.83% 0.00%
31-Dec-2014 25-Feb-2015 31-Dec-2014 4 123,305 12,671 9,545 9,545 7,028 260,064 73.64% 7.74% 3.67% 117,146 105.26 25.96 8.13 2.01 6.00 1.48 2.2200 0.55   28.81%   24.89% 31-Dec-2014 3.58 3.40 43.94 1.61 2.28% 1.68% 25-Feb-2015 3.64 3.46 44.67 1.64 2.24% 1.65%
31-Dec-2014 18-Nov-2014 30-Sep-2014 3 122,512 10,281 7,410 7,410 - 249,520 - % 6.05% 2.97% 117,146 104.58 25.79 6.30 1.56 0.00 0.00 2.1300 0.53   -1.91%   14.37% 30-Sep-2014 3.86 3.69 61.02 1.81 1.64% 0.00% 18-Nov-2014 3.70 3.54 58.49 1.74 1.71% 0.00%
31-Dec-2014 20-Aug-2014 30-Jun-2014 2 122,493 10,050 7,554 7,554 4,100 246,006 54.28% 6.17% 3.07% 117,146 104.56 25.79 6.42 1.59 3.50 0.86 2.1000 0.52   -20.22%   10.89% 30-Jun-2014 3.80 3.63 58.93 1.81 1.70% 0.92% 20-Aug-2014 3.85 3.68 59.71 1.83 1.67% 0.91%
31-Dec-2014 21-May-2014 31-Mar-2014 1 130,927 12,622 9,468 9,468 - 244,601 - % 7.23% 3.87% 93,717 139.70 27.56 10.07 1.99 0.00 0.00 2.6100 0.51   23.88%   3.90% 31-Mar-2014 4.60 3.29 45.53 1.76 2.20% 0.00% 21-May-2014 4.80 3.44 47.51 1.84 2.10% 0.00%
31-Dec-2013 26-Feb-2014 31-Dec-2013 4 106,210 10,566 7,643 7,643 5,621 235,161 73.55% 7.20% 3.25% 93,690 113.36 22.36 6.50 1.61 6.00 1.18 2.5100 0.50   17.97%   -3.13% 31-Dec-2013 4.50 3.97 55.16 1.79 1.81% 1.33% 26-Feb-2014 4.40 3.88 53.94 1.75 1.85% 1.36%
31-Dec-2013 20-Nov-2013 30-Sep-2013 3 101,680 8,579 6,512 6,479 - 225,030 - % 6.40% 2.88% 93,762 108.44 21.41 6.91 1.36 0.00 0.00 2.4000 0.47   -4.89%   0.61% 30-Sep-2013 4.80 4.43 69.46 2.00 1.44% 0.00% 20-Nov-2013 4.79 4.42 69.32 2.00 1.44% 0.00%
31-Dec-2013 21-Aug-2013 30-Jun-2013 2 104,202 9,273 6,833 6,812 3,748 223,006 55.02% 6.56% 3.05% 93,700 111.21 21.94 7.27 1.43 4.00 0.79 2.3800 0.47   -25.25%   -18.54% 28-Jun-2013 4.49 4.04 61.76 1.89 1.62% 0.89% 21-Aug-2013 4.95 4.45 68.09 2.08 1.47% 0.81%
31-Dec-2013 22-May-2013 31-Mar-2013 1 106,359 12,197 9,134 9,113 - 225,949 - % 8.59% 4.03% 93,755 113.44 22.39 9.72 1.92 0.00 0.00 2.4100 0.48   15.50%   44.19% 29-Mar-2013 4.27 3.76 43.93 1.77 2.28% 0.00% 22-May-2013 4.37 3.85 44.96 1.81 2.22% 0.00%
31-Dec-2012 27-Feb-2013 31-Dec-2012 4 95,993 9,918 7,898 7,890 10,312 216,569 130.71% 8.23% 3.64% 93,752 102.39 20.21 8.42 1.66 11.00 2.17 2.3100 0.46   22.52%   -1.38% 31-Dec-2012 3.68 3.59 43.73 1.59 2.29% 2.99% 27-Feb-2013 4.14 4.04 49.19 1.79 2.03% 2.66%
31-Dec-2012 21-Nov-2012 30-Sep-2012 3 97,807 8,771 6,457 6,440 - 208,104 - % 6.60% 3.09% 93,740 104.34 20.59 6.87 1.36 0.00 0.00 2.2200 0.44   -22.98%   39.79% 28-Sep-2012 3.28 3.14 47.74 1.48 2.09% 0.00% 21-Nov-2012 3.56 3.41 51.82 1.60 1.93% 0.00%
31-Dec-2012 15-Aug-2012 30-Jun-2012 2 100,678 11,333 8,374 8,362 5,624 206,237 67.26% 8.32% 4.05% 93,744 107.40 21.19 8.92 1.76 6.00 1.18 2.2000 0.43   32.31%   28.19% 29-Jun-2012 2.95 2.75 33.07 1.34 3.02% 2.03% 15-Aug-2012 3.11 2.90 34.87 1.41 2.87% 1.93%
31-Dec-2012 23-May-2012 31-Mar-2012 1 104,126 12,327 6,337 6,320 - 205,353 - % 6.09% 3.08% 93,768 111.05 21.92 6.74 1.33 0.00 0.00 2.1900 0.43   -21.00%   -28.78% 30-Mar-2012 2.94 2.65 43.62 1.34 2.29% 0.00% 23-May-2012 2.78 2.50 41.25 1.27 2.42% 0.00%
31-Dec-2011 23-Feb-2012 31-Dec-2011 4 92,330 9,314 7,992 8,000 9,376 198,784 117.21% 8.66% 4.02% 93,766 98.47 19.44 8.54 1.68 10.00 1.97 2.1200 0.42   73.65%   -39.46% 30-Dec-2011 2.74 2.78 32.11 1.29 3.11% 3.65% 23-Feb-2012 2.83 2.87 33.17 1.33 3.01% 3.53%
31-Dec-2011 15-Nov-2011 30-Sep-2011 3 91,867 6,125 4,623 4,607 - 190,085 - % 5.03% 2.42% 93,638 98.11 19.34 4.92 0.97 0.00 0.00 2.0300 0.40   -29.37%   -36.21% 30-Sep-2011 2.60 2.65 52.85 1.28 1.89% 0.00% 15-Nov-2011 2.84 2.89 57.72 1.40 1.73% 0.00%
31-Dec-2011 19-Aug-2011 30-Jun-2011 2 88,983 8,738 6,666 6,523 5,153 189,284 79.01% 7.49% 3.45% 93,705 94.96 18.73 6.96 1.37 5.50 1.08 2.0200 0.40   -26.49%   12.47% 30-Jun-2011 3.05 3.21 43.81 1.51 2.28% 1.80% 19-Aug-2011 2.92 3.07 41.95 1.45 2.38% 1.88%
31-Dec-2011 19-May-2011 31-Mar-2011 1 92,822 11,601 9,115 8,874 - 190,200 - % 9.82% 4.67% 93,694 99.07 19.54 9.47 1.87 0.00 0.00 2.0300 0.40   -32.85%   32.37% 31-Mar-2011 2.90 2.93 30.62 1.43 3.27% 0.00% 19-May-2011 3.00 3.03 31.68 1.48 3.16% 0.00%
31-Dec-2010 24-Feb-2011 31-Dec-2010 4 77,454 19,327 17,691 13,215 8,435 182,760 63.83% 22.84% 7.23% 93,723 82.64 16.31 14.10 2.78 9.00 1.78 1.9500 0.38   82.98%   51.32% 30-Dec-2010 2.59 3.13 18.37 1.33 5.44% 3.47% 24-Feb-2011 2.68 3.24 19.01 1.37 5.26% 3.36%
31-Dec-2010 23-Nov-2010 30-Sep-2010 3 81,613 9,092 7,682 7,222 - 169,543 - % 9.41% 4.26% 93,670 87.13 17.18 7.71 1.52 0.00 0.00 1.8100 0.36   24.52%   45.43% 30-Sep-2010 2.53 2.90 32.81 1.40 3.05% 0.00% 23-Nov-2010 2.52 2.89 32.68 1.39 3.06% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more.
  4 people like this.
 
iskandar5156 Malaysia accounts for 70% of Apex Healthcare’s revenue currently, followed by Singapore, Myanmar and Hong Kong. In addition, the group also exports to 12 other countries
25/07/2020 12:26 PM
iskandar5156 Ahealth has distribution partnership with those vaccine manufacturer for more than 20 years. They might not be able to get it for Malaysia, but Apex has big exposure to Indonesia and Singapore.

" Apex Pharmacy Marketing Sdn Bhd (APM) and Apex Pharma
Marketing Pte Ltd (APS) undertake the Group’s wholesale and
distribution activities. Having 8 warehouses in Malaysia and 1
warehouse in Singapore, Apex Healthcare distributes over 5,000 of
its in-house and third parties’ pharmaceuticals and consumer
healthcare products to hospitals, clinics, pharmacies, supermarkets,
and health stores throughout Malaysia and Singapore. Some of its
third-party clients include multinational pharmaceutical companies
such as GlaxoSmithKline, Ranbaxy, Pfizer, Novartis, AstraZeneca,
and Roche.
25/07/2020 12:28 PM
pang72 All healthcare stocks will resume upward trend from Monday onward.
Ahealth is another company never register loss in quarter so far.

This company is good for investment.
26/07/2020 4:01 PM
pang72 We are expected V sharp rebound
26/07/2020 4:02 PM
Newbieinshare forget about pharmaceutical stock la.... how long it takes for covid19 vaccine to be available? How much can u earn from the vaccine distribution? Ahealth just kena goreng-ed cause pharma and Dpharma kena goreng as well.
Go for those counters/sectors that are still silent and still cold.
Such as construction or plantation.
And dont forget, pls check the CPO price. It has creeping up from 2300 beginning of the month to now almost 2800. I personally think plantation is the next hot sector follow-by contruction and pharmaceutical is nearly game-over.
26/07/2020 7:04 PM
Newbieinshare If u looking for covid19 theme counter. UEMS-Edgenta is another forgotten one. Edgenta has lots of contract with various hospital in the world and its business not only in Malaysia, but also in Singapore,Indonesia and even Taiwan. And we all know. due to this covid19, many premises/public places/transport need to be constantly sanitized/disinfect and Edgenta is involved in this business for very long. Also personally think it will benefit from this crisis. But pls do own research before making any decision
26/07/2020 7:07 PM
mf WASHINGTON: The United States has doubled its investment - to nearly US$1 billion - to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday (Jul 27) begins the decisive final phase of clinical trials.
27/07/2020 10:13 AM
chshzhd ahealth is always a good caunter to invest even without any other catalyst ie vaccine .. :> ..
27/07/2020 11:47 AM
Benlee88888 https://www.klsescreener.com/v2/news/view/708103
28/07/2020 10:12 PM
Benlee88888 https://www.klsescreener.com/v2/news/view/708067
28/07/2020 10:54 PM
Benlee88888 https://www.malaysianewslab.com/local-news/vaccine3/

now every pharmaceutical company has a chance!!
29/07/2020 9:55 AM
mf RHB downgrades Duopharma to 'sell' following overdose of vaccine hope
Areeshya Thevamanohar
/
theedgemarkets.com

July 29, 2020 10:43 am +08
29/07/2020 12:18 PM
chshzhd good move ..
03/08/2020 4:04 PM
chshzhd bravo
05/08/2020 12:25 PM
LiimInvest Fundamental
05/08/2020 1:12 PM
DrLimKH Wholesaler with Apex Pharmacy chain.... not manufacturer
07/08/2020 8:23 PM
sour_grape_so_sour actually ubat also down since last week.....it it the liquidity draining away
12/08/2020 7:38 AM
ikenduit when is the awesome QR coming out?
19/08/2020 10:25 AM
chwenshiangan any news
24/08/2020 3:21 PM
awesomeliddat good fundamental, promising
24/08/2020 9:20 PM
LA777 Ahealth go go go!!!
25/08/2020 12:05 PM
LA777 Buy to keep, 1st TP 6.
25/08/2020 12:07 PM
1Anchovy Can still buy in at this price?
25/08/2020 12:49 PM
LA777 Good fundamental stock, buy now before shooting up soon!!!
25/08/2020 1:13 PM
Sinoboy Also goreng counter, from 4.18 to 3.96 in half hour...
25/08/2020 1:46 PM
thundery Purely Goreng, stay away
25/08/2020 5:13 PM
Coffin Dance Ahealth is a good counter all the while just that the current pricing have element of speculation
25/08/2020 5:53 PM
CharKuayTeow i also think this one goreng goreng gila babi
26/08/2020 8:46 AM
jowong7 INTERIM FINANCIAL STATEMENTS FOR THE SECOND QUARTER ENDED 30 JUNE 2020

"Expansion of cold chain distribution facilities, essential for vaccine distribution, has been completed in Singapore and will be completed by the fourth quarter in Malaysia."
26/08/2020 7:05 PM
jowong7 Capacity Increase for Cold Chain Vaccine Distribution In addition, the Group also reported that expansion of its cold chain distribution facilities, essential for vaccine distribution, has been completed in Singapore and will be completed by the fourth quarter of 2020 in Malaysia.
“For many years now, we have been supplying a wide range of vaccines and biologicals under cold chain distribution specifications directly to many healthcare professionals in Malaysia and Singapore. The planned capacity increase is timely as volume is growing. We will also be ready to play our role in the supply chain when vaccines for COVID-19 become available” added Dr Kee
26/08/2020 7:15 PM
khuen Vaccine distribution! Thumbs Up!
26/08/2020 10:04 PM
JaBerry Quarter report good. Business growth. Facemask, santinizer, Vit C, Thermometer etc all up.
27/08/2020 9:29 AM
newinvestor17 A report published by Sui Li of PBB stated that there were no suprises in this counter ?

Nabeh KNN MCB, this analyst really knows how to value companies ka ? I am suprised that she didnt find any suprises.

This analyst must be one sei so hai who randomly writes reports based on her mood, just look at her Top Glove reports KNN

Her two bosses never checks her report before publishing ka ?

When a counters TP should be increased, they decrease it and when it should be decreased, they increase it

Really no direction punya amoi and research house
27/08/2020 10:13 AM
enigmatic [control your emotions, discipline your mind] Then write an analysis report which is better than hers to "teach" her. Empty cans make the most noise.
27/08/2020 10:45 AM
chshzhd cheaper than dpharma ..
28/08/2020 10:46 AM
chshzhd Just a myth. Contrary to popular belief, pharmaceutical companies like ApexH are also faced with an uncertain outlook for 2H2020 due to disruptions caused by the pandemic. Weaker consumer sentiment and cautious spending has impacted ApexH’s sales, while the deferment elective medical procedures like orthopaedic surgeries has resulted in lower demand for Straits Apex’s orthopaedic devices. However, during this tough time, ApexH has also completed its cold chain distribution expansion in Singapore, while the expansion in Malaysia is expected to complete in 4QFY20. Given that cold chain distribution is vital for the distribution of vaccine, we are positive on this timely expansion as ApexH would be able to expand into vaccine distribution, be it a Covid-19 vaccine or other vaccines available. However, contrary to market’s belief, we are not expecting immediate benefit arising from any potential vaccine distribution by Apex
Source: PublicInvest Research - 27 Aug 2020
28/08/2020 10:37 PM
LiimInvest Growing & Fundamental
29/08/2020 11:06 PM
mayongzheng https://youtu.be/eIgQAOLapj8
01/09/2020 8:54 PM
Wilfred51a https://news.cgtn.com/news/2020-09-11/Hundreds-of-thousands-have-been-given-Chinese-COVID-19-vaccines-THnoo6BcFG/index.html
12/09/2020 8:29 PM
Benlee88888 https://www.klsescreener.com/v2/news/view/728195
15/09/2020 9:33 PM
Benlee88888 Ini kali lah
15/09/2020 9:33 PM
LiimInvest Next TP over 5.00
15/09/2020 10:41 PM
GorengHealthcare joined to goreng
16/09/2020 10:01 PM
humongainz brother goreng oil la healthcare how can use for goreng aiyaiyai
16/09/2020 10:03 PM
hahasong United States vaccine failed!

The glove unit ESCERAM 0100 is about to fly!
17/09/2020 9:33 AM
Wilfred51a https://www.theedgemarkets.com/article/malaysia-join-covax-vaccine-plan
20/09/2020 7:50 PM
Alfonso jom nasi goreng to the best of the best
25/09/2020 4:29 PM
LiimInvest 吉隆坡1日讯)紧随政府的疫苗采购有进展,驱动大马股市的疫苗概念股在10月第一个交易日纷纷上涨。

发马联合药业受激励

受政府委定为疫苗灌封商的发马(PHARMA,7081,主板医疗保健组)受消息激励,闭市涨38仙(8.8%)至4令吉70仙;联合药业(DPHARMA,7148,主板医疗保健组)起32仙(10.1%)至3令吉48仙,双双跻身10大上涨股。

上述两股皆以接近最高与最高收市,发马成交量176万7600股,联合药业1629万6500股成交。

另一医疗保健股艾柏士保健(AHEALTH,7090,主板医疗保健组)涨9仙至3令吉33仙。

他说,政府通过多种管道和层面去洽谈采购疫苗,并希望越快越好。

“一旦获得卫生部旗下的大马药剂监管局(NPRA)批准,我国尽量在最短的时间内取得或购买冠病疫苗。”
01/10/2020 11:45 PM
50Cents Post removed. Why?
08/10/2020 1:22 AM
NPRA1985 How are the fundamentals of this stock? Good or bad?
25/10/2020 12:22 AM